A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 6, Issue 3, Pages e1686
Publisher
Springer Nature
Online
2015-03-13
DOI
10.1038/cddis.2015.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- Novel Benzimidazole Analogs as Inhibitors of EGFR Tyrosine Kinase
- (2012) Soni Yadav et al. Chemical Biology & Drug Design
- Small-molecule activation of the TRAIL receptor DR5 in human cancer cells
- (2012) Gelin Wang et al. Nature Chemical Biology
- Diesel exhaust increases EGFR and phosphorylated C-terminal Tyr 1173 in the bronchial epithelium
- (2012) Jamshid Pourazar et al. Particle and Fibre Toxicology
- Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
- (2011) Yunqi Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Differences underlying EGFR and HER2 oncogene addiction
- (2011) Anthony C. Faber et al. CELL CYCLE
- Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation
- (2011) N. G. Dolloff et al. Science Translational Medicine
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- The role of HER2 in cancer therapy and targeted drug delivery
- (2010) Wanyi Tai et al. JOURNAL OF CONTROLLED RELEASE
- Design and Synthesis of 2-Arylbenzimidazoles and Evaluation of Their Inhibitory Effect againstChlamydia pneumoniae
- (2010) Leena Keurulainen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones
- (2008) Deepika Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started